Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ANI Pharma Inc (NQ: ANIP )

38.62 +0.24 (+0.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 73,982
Open 38.50
Bid (Size) 37.37 (1)
Ask (Size) 39.99 (1)
Prev. Close 38.38
Today's Range 37.27 - 39.98
52wk Range 22.31 - 45.83
Shares Outstanding 24,422,240
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ANI Pharmaceuticals Earnings Perspective: Return On Capital Employed
 
Via Benzinga
ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance
From ANI Pharmaceuticals, Inc.
Via Business Wire

Performance

YTD
-3.55%
-3.55%
1 Month
-7.67%
-7.67%
3 Month
-0.62%
-0.62%
6 Month
+24.18%
+24.18%
1 Year
+37.10%
+37.10%

More News

Read More
Guggenheim Creates Bullish Pitch For ANI Pharma On Progress With Cortrophin Launch
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
Via Benzinga
ANI Pharmaceuticals's Return On Capital Employed Overview
Via Benzinga
ANI Pharmaceuticals: Q2 Earnings Insights
Via Benzinga
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023, at 8:30 a.m. ET
From ANI Pharmaceuticals, Inc.
Via Business Wire
Organon Stock Scores Market Leadership With Jump To 83 RS Rating
Via Investor's Business Daily
ANI Pharmaceuticals Announces the FDA Approval and Launch of Levocarnitine Tablets USP
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP
From ANI Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
ANI Pharmaceuticals Announces the FDA Approval and Launch of Trimethoprim Tablets USP
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Reports Third Quarter 2022 Financial Results; Reports Record Net Revenues
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals to Discuss Third Quarter 2022 Financial Results on November 9, 2022, at 8:00 a.m. ET
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Appoints Krista Davis as Chief Human Resources Officer
From ANI Pharmaceuticals, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Via Benzinga
ANI Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces the Launch of Prochlorperazine Maleate Tablets USP
From ANI Pharmaceuticals, Inc.
Via Business Wire
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Dexamethasone Tablets USP
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin® Gel
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces the Launch of Acebutolol Hydrochloride Capsules USP
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Acquires ANDAs from Oakrum Pharma, LLC
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET
From ANI Pharmaceuticals, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.